USA – First trial of a vaccine against Alzheimer’s launches

Researchers in the US hope that the vaccine can stimulate the brain’s immune system to clear the amyloid plaques seen in Alzheimer’s

For some time, researchers have looked to the brain’s immune system as a key factor in the development of Alzheimer’s disease. Now, after years of lab work, patients with Alzheimer’s disease are set to receive a vaccine that stimulates the immune system in the hope it will slow or even prevent the disease.

The first-in-human trial run by the Brigham and Women’s Hospital (BWH) in Boston, Massachusetts, will involve an intranasal vaccine using the immune modulator Protollin, an investigational intranasal agent that stimulates the immune system…